U.S., Nov. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07241923) titled 'A Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SYH2070 Injection' on Nov. 17.
Brief Summary: This is a randomized, double-blind, placebo-controlled, single ascending dose (SAD) study of SYH2070 injection when administered subcutaneously to healthy subjects.
Study Start Date: Nov. 17
Study Type: INTERVENTIONAL
Condition:
Healthy Subjects (HS)
Intervention:
DRUG: SYH2070 injection
subcutaneous injection
DRUG: Placebo
subcutaneous injection
Recruitment Status: NOT_YET_RECRUITING
Sponsor: CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd.
Published by HT Digita...